Equities

Unilever Indonesia Tbk PT

Unilever Indonesia Tbk PT

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (IDR)1,795.00
  • Today's Change55.00 / 3.16%
  • Shares traded11.68m
  • 1 Year change-48.71%
  • Beta-0.0314
Data delayed at least 10 minutes, as of Nov 22 2024 09:09 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Unilever Indonesia Tbk is an Indonesia-based fast-moving consumer goods (FMCG) company. The Company is engaged in the manufacturing, marketing, and distribution of consumer goods, including soaps, detergents, dairy based foods, ice cream, cosmetic products, tea-based beverages and fruit juice, and office space leasing. The Company's segments include Home and Personal Care and Foods and Refreshments. The Home and Personal Care segment includes cleaning products, which are used in the household and cosmetic products. The Foods and Refreshments segment includes food and beverage products, including ice cream. The Company operates approximately 40 brands. Some of its brands are Lifebuoys, Sunlight, Pepsodent, Bango, Rexona, Wall's, Sunsilk, Clear, Dove, Royco, Vaseline, SariWangi, Rinso, Glow & Lovely, and Buavita.

  • Revenue in IDR (TTM)35.52tn
  • Net income in IDR3.62tn
  • Incorporated1933
  • Employees4.45k
  • Location
    Unilever Indonesia Tbk PTBSD CityTANGERANG 15345IndonesiaIDN
  • Phone+62 2 180827000
  • Fax+62 2 180827002
  • Websitehttps://www.unilever.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pola Orbis Holdings Inc17.72tn755.26bn32.17tn4.05k41.181.8620.141.8233.0833.08776.57734.440.87131.8010.8242,501,240.003.735.374.276.1881.8482.844.286.273.12--0.0003124.314.21-6.96-15.562.8712.16-8.25
Fancl Corp11.23tn728.26bn37.53tn1.28k47.994.1733.053.3458.2258.22898.03670.811.062.789.1685,425,550.006.897.988.669.6366.9268.586.497.002.99388.100.0052.357.03-1.9777.730.4219-7.932.53
Kose Corp32.99tn816.89bn42.31tn7.56k48.771.4522.701.28138.93138.935,611.064,680.690.87321.297.4742,361,740.002.49--3.20--69.60--2.85--2.64--0.0328--3.90---37.87------
Blue Moon Group Holdings Ltd16.84tn-349.84bn45.47tn7.46k--2.37281.002.70-0.0317-0.03171.481.600.73058.139.031,034,556.00-1.527.71-1.759.5562.5561.25-2.0811.766.30--0.013156.21-7.841.59-46.79-10.10-5.28--
Kobayashi Pharmaceutical Co Ltd17.39tn1.05tn45.71tn3.53k41.672.0624.822.63136.38136.382,265.482,753.510.64752.694.0147,764,290.003.918.014.6910.1853.8956.456.0312.242.45--0.004733.194.330.70371.582.4529.678.88
Emami Ltd6.94tn1.46tn52.16tn3.29k35.8310.5329.087.5117.7017.7084.3860.221.073.287.6211,201,660.0022.2520.4329.7127.9168.2465.5620.8718.751.5741.960.027553.895.065.8513.1319.00-21.8514.87
Lion Corp42.03tn1.90tn52.73tn7.55k27.291.7712.261.2565.9365.931,459.941,014.740.8683.715.6554,016,950.004.485.636.598.9345.8247.605.176.451.28--0.095931.013.312.88-33.34-10.609.215.39
Hengan International Group Company Ltd51.43tn6.56tn54.34tn24.00k8.201.196.311.062.792.7921.8619.270.49354.018.681,092,839.006.297.7013.6015.9134.8737.1412.7514.791.1012.230.495565.995.092.9945.46-5.9215.95-9.05
Gillette India Limited5.18tn851.88bn56.34tn523.0066.13--56.0010.88138.72138.72843.17--------52,530,590.00--20.47--33.0358.5652.8716.4514.45--62.76--90.386.307.1815.7510.24-2.2815.39
Unilever Indonesia Tbk PT35.52tn3.62tn66.38tn4.45k18.3319.3214.531.8794.9494.94931.1490.072.007.6011.067,740,902,000.0020.4231.4056.6988.3348.6850.4510.2014.850.292776.630.212101.38-6.33-1.58-10.51-11.97-4.74-9.99
Proya Cosmetics Co Ltd23.37tn3.18tn80.60tn2.97k25.737.57--3.453.593.5926.3812.211.482.9444.813,575,240.0020.6015.5428.4721.6168.5266.5813.9212.832.49--0.153830.1539.4530.4146.0632.97-4.8042.52
Data as of Nov 22 2024. Currency figures normalised to Unilever Indonesia Tbk PT's reporting currency: Indonesian Rupiah IDR

Institutional shareholders

3.03%Per cent of shares held by top holders
HolderShares% Held
First Sentier Investors (Hong Kong) Ltd.as of 31 Jul 2024365.83m0.96%
The Vanguard Group, Inc.as of 06 Nov 2024212.14m0.56%
BlackRock Fund Advisorsas of 07 Nov 2024146.63m0.38%
Norges Bank Investment Managementas of 30 Jun 2024107.58m0.28%
BlackRock Advisors (UK) Ltd.as of 08 Nov 202485.39m0.22%
Prusik Investment Management LLPas of 31 Jul 202460.00m0.16%
First Sentier Investors (Australia) IM Ltd.as of 30 Jun 202450.75m0.13%
Geode Capital Management LLCas of 14 Nov 202449.07m0.13%
Dimensional Fund Advisors LPas of 07 Nov 202441.27m0.11%
JPMorgan Asset Management (UK) Ltd.as of 31 Oct 202438.30m0.10%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.